Author: Val Jurkauskas

Val has 20 years of pharmaceutical experience spanning CMC strategy, process development, and global manufacturing networks that secure clinical supply and regulatory milestones. He has guided programs from early development through commercialization—including fast-track, orphan, and breakthrough therapy designations—and has led commercial process validations, marketing applications, and health-authority interactions worldwide. Val earned a PhD in Organic Chemistry from the Massachusetts Institute of Technology and a BS with honors in Chemistry from the University of Toronto.